Rocket Pharmaceuticals Public Equity Offering

Rocket Pharmaceuticals, Inc. is a fully integrated, commercial-stage biotechnology company focused on advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need. The company has recently strengthened its financial position through the sale of a Rare Pediatric Disease Priority Review Voucher (PRV) for $180 million.